Here’s how much pharma executives are paying for real-world data — and who they’re buying data from

Real-world data (RWD) is transforming the drug R&D value chain. RWD — an umbrella term for patient data mined from health records, insurance claims, clinical registries, genomic databases, and surveys of patient-reported outcomes — was initially used to collect evidence about a drug‘s post-market safety.Today, these datasets are being used to match patients to the […]